• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® VIABAHN® ENDOPROSTHESIS; NIP Back to Search Results
Catalog Number JHJR061002J
Device Problem Patient-Device Incompatibility (2682)
Patient Problem Thrombosis (2100)
Event Date 12/27/2017
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records for the device could not be conducted as lot number of the device was not available.According to the gore® viabahn® endoprosthesis instructions for use (ifu), device-related complications and adverse events include, but are not limited to thrombosis or occlusion of device.(b)(4).
 
Event Description
On an unknown date, the patient underwent an arterio-venous shunt procedure whereby a non-gore manufactured vascular graft was implanted in the patient¿s upper arm.Later, the vascular graft stenosis had been revealed for multiple times.On (b)(6) 2017, the patient was implanted with a gore® viabahn® endoprosthesis (jhjr061002j with an unknown lot number) to repair the graft stenosis.The patient tolerated the procedure.On (b)(6) 2017, thrombosis of the existing endoprosthesis was revealed.On the same day, thrombectomy as well as percutaneous balloon angioplasty (pta) were performed.On (b)(6) 2018, recurrent thrombosis of the existing endoprosthesis was revealed.On the same day, thrombectomy as well as pta were performed.The patient tolerated the reintervention procedure.
 
Manufacturer Narrative
Device available for evaluation corrected this section to "yes" and put 2/15/2018 as the date of device return.Results of explant evaluation: device fragments involved in this reported event were received by gore from your institution and an explant evaluation was performed.Histopathological examination of the device fragments confirmed that luminal tissue typically consisted of acute thrombus.There were some regions in a couple of device fragments that represented blood stasis which is a non-physiologic response to the cessation of blood flow at the completion of device explantation.There was no evidence of infection in any submitted device fragments.The primary cause of endoprosthesis occlusion was not identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7295443
MDR Text Key100888250
Report Number2017233-2018-00126
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P130006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 09/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberJHJR061002J
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/15/2018
Was the Report Sent to FDA? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/25/2018
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received09/10/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-